These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

747 related items for PubMed ID: 17681453

  • 1. The SKATE study: an open-label community-based study of levetiracetam as add-on therapy for adults with uncontrolled partial epilepsy.
    Steinhoff BJ, Somerville ER, Van Paesschen W, Ryvlin P, Schelstraete I.
    Epilepsy Res; 2007 Aug; 76(1):6-14. PubMed ID: 17681453
    [Abstract] [Full Text] [Related]

  • 2. Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in Chinese patients with refractory partial-onset seizures.
    Wu XY, Hong Z, Wu X, Wu LW, Wang XF, Zhou D, Zhao ZX, Lv CZ.
    Epilepsia; 2009 Mar; 50(3):398-405. PubMed ID: 18657175
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of levetiracetam 1000-3000 mg/day in patients with refractory partial-onset seizures: a multicenter, open-label single-arm study.
    Beran RG, Berkovic SF, Black AB, Danta G, Hiersemenzel R, Schapel GJ, Vajda FJ.
    Epilepsy Res; 2005 Jan; 63(1):1-9. PubMed ID: 15716083
    [Abstract] [Full Text] [Related]

  • 4. Once-daily extended-release levetiracetam as adjunctive treatment of partial-onset seizures in patients with epilepsy: a double-blind, randomized, placebo-controlled trial.
    Peltola J, Coetzee C, Jiménez F, Litovchenko T, Ramaratnam S, Zaslavaskiy L, Lu ZS, Sykes DM, Levetiracetam XR N01235 Study Group.
    Epilepsia; 2009 Mar; 50(3):406-14. PubMed ID: 19317886
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of levetiracetam (3,000 mg/Day) as an adjunctive therapy in Chinese patients with refractory partial seizures.
    Xiao Z, Li JM, Wang XF, Xiao F, Xi ZQ, Lv Y, Sun HB.
    Eur Neurol; 2009 Mar; 61(4):233-9. PubMed ID: 19176965
    [Abstract] [Full Text] [Related]

  • 6. Adjunctive levetiracetam in infants and young children with refractory partial-onset seizures.
    Piña-Garza JE, Nordli DR, Rating D, Yang H, Schiemann-Delgado J, Duncan B, Levetiracetam N01009 Study Group.
    Epilepsia; 2009 May; 50(5):1141-9. PubMed ID: 19243423
    [Abstract] [Full Text] [Related]

  • 7. Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures.
    Glauser TA, Ayala R, Elterman RD, Mitchell WG, Van Orman CB, Gauer LJ, Lu Z, N159 Study Group.
    Neurology; 2006 Jun 13; 66(11):1654-60. PubMed ID: 16641323
    [Abstract] [Full Text] [Related]

  • 8. Levetiracetam intravenous infusion as an alternative to oral dosing in patients with partial-onset seizures.
    Baulac M, Brodie MJ, Elger CE, Krakow K, Stockis A, Meyvisch P, Falter U.
    Epilepsia; 2007 Mar 13; 48(3):589-92. PubMed ID: 17326794
    [Abstract] [Full Text] [Related]

  • 9. Adjunctive therapy of uncontrolled partial seizures with levetiracetam in Australian patients.
    Somerville ER, McLaughlin DB, Robinson MK, Berkovic SF.
    Epilepsy Behav; 2007 Nov 13; 11(3):338-42. PubMed ID: 17851135
    [Abstract] [Full Text] [Related]

  • 10. Levetiracetam in a broad population of patients with refractory epilepsy: interim results of the international SKATE trial.
    Genton P, Sadzot B, Fejerman N, Peltola J, Despland PA, Steinhoff B, Rektor I, Wroe S, Maubrey MC, Vandervelden C, van Hammée G, Schlit AF, van Paesschen W.
    Acta Neurol Scand; 2006 Jun 13; 113(6):387-94. PubMed ID: 16674605
    [Abstract] [Full Text] [Related]

  • 11. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study.
    Callenbach PM, Arts WF, ten Houten R, Augustijn P, Gunning WB, Peeters EA, Weber AM, Stroink H, Geerts Y, Geerts AT, Brouwer OF.
    Eur J Paediatr Neurol; 2008 Jul 13; 12(4):321-7. PubMed ID: 17950011
    [Abstract] [Full Text] [Related]

  • 12. Use of levetiracetam in hospitalized patients.
    Falip M, Carreño M, Amaro S, Donaire A, Delgado R, Toledo M, Maestro I.
    Epilepsia; 2006 Dec 13; 47(12):2186-8. PubMed ID: 17201722
    [Abstract] [Full Text] [Related]

  • 13. Effects of levetiracetam as an add-on therapy on cognitive function and quality of life in patients with refractory partial seizures.
    Zhou B, Zhang Q, Tian L, Xiao J, Stefan H, Zhou D.
    Epilepsy Behav; 2008 Feb 13; 12(2):305-10. PubMed ID: 18024209
    [Abstract] [Full Text] [Related]

  • 14. Levetiracetam in patients with refractory epilepsy: results of the SKATE trial in Austria, Germany and Switzerland.
    Steinhoff BJ, Trinka E, Wieser HG, DACH-LEV Study Group.
    Seizure; 2005 Oct 13; 14(7):490-6. PubMed ID: 16169256
    [Abstract] [Full Text] [Related]

  • 15. The SKATE study: interim analysis.
    Olwen GO.
    Int J Clin Pract; 2003 Oct 13; 57(6):544-5. PubMed ID: 12918896
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of levetiracetam: a review of three pivotal clinical trials.
    Privitera M.
    Epilepsia; 2001 Oct 13; 42 Suppl 4():31-5. PubMed ID: 11564123
    [Abstract] [Full Text] [Related]

  • 17. Onset of action of levetiracetam: a RCT trial using therapeutic intensive seizure analysis (TISA).
    Stefan H, Wang-Tilz Y, Pauli E, Dennhöfer S, Genow A, Kerling F, Lorber B, Fraunberger B, Halboni P, Koebnick C, Gefeller O, Tilz C.
    Epilepsia; 2006 Mar 13; 47(3):516-22. PubMed ID: 16529615
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of levetiracetam as adjunctive treatment of refractory partial seizures in a multicentre open-label single-arm trial in Korean patients.
    Heo K, Lee BI, Yi SD, Huh K, Kim JM, Lee SA, Shin DJ, Song HK, Lee SK, Kim JY, Lu S, Dubois C, Tonner F.
    Seizure; 2007 Jul 13; 16(5):402-9. PubMed ID: 17369059
    [Abstract] [Full Text] [Related]

  • 19. Neurocognitive effects of adjunctive levetiracetam in children with partial-onset seizures: a randomized, double-blind, placebo-controlled, noninferiority trial.
    Levisohn PM, Mintz M, Hunter SJ, Yang H, Jones J, N01103 Levetiracetam Study Group.
    Epilepsia; 2009 Nov 13; 50(11):2377-89. PubMed ID: 19702752
    [Abstract] [Full Text] [Related]

  • 20. Dose-dependent safety and efficacy of zonisamide: a randomized, double-blind, placebo-controlled study in patients with refractory partial seizures.
    Brodie MJ, Duncan R, Vespignani H, Solyom A, Bitenskyy V, Lucas C.
    Epilepsia; 2005 Jan 13; 46(1):31-41. PubMed ID: 15660766
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.